Patients with only dry eye had less severe lid margin abnormalities and orifice plugging along with tear film instability ...

New findings reveal RG6501 cell therapy shows promising long-term visual improvements for geographic atrophy patients ...

Washington University researchers found that raising a molecule called ApoM helps eye cells sweep away harmful cholesterol ...

A new study reveals that increasing levels of apolipoprotein M (ApoM) may slow or prevent the progression of age-related macular degeneration (AMD), a major cause of blindness in older adults.

Fixing problems with cholesterol metabolism might help slow or prevent a common cause of age-related vision loss, a new WashU ...

Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...

Patients treated with pegcetacoplan have better visual acuity and quality of life results when lesions are farther from foveal center.

13. Autosomal Dominant Optic Atrophy: Seven Major Market Analysis 14. Autosomal Dominant Optic Atrophy Unmet Needs 15. SWOT Analysis 16. KOL Views 17. Market Access and Reimbursement 18. Appendix 19.

Geographic atrophy (GA) is the late stage of age-related macular degeneration (AMD) and may lead to vision loss. Find out about the stages of progression and how you can prepare for them.

Slowing Geographic Atrophy Progression: Oral Antioxidants Show Promise —A post-hoc analysis assessed micronutrient supplementation, including lutein and zeaxanthin, to determine if it slows ...